MIT radar technology fights breast cancer

In this study, large tumors treated with a combination of chemotherapy and a focused microwave heat treatment shrunk nearly 50 percent more than tumors treated with chemotherapy alone. The microwave treatment is based on technology originally developed at MIT in the late 1980s as a tool for missile detection.

“It appears that heating the tumors drastically increased the effectiveness of the chemotherapy,” said Dr. William C. Dooley, director of surgical oncology at the University of Oklahoma and the principal investigator of the study. “The tumors shrank faster and died faster using the additional microwave hyperthermia on top of the chemotherapy.”

According to the National Cancer Institute, some 178,000 women and 2,000 men were diagnosed with breast cancer in 2007. An estimated 40,000 women and 450 men will die of the disease this year.

In the latest clinical trial, fifteen patients received two microwave heat treatments, known as thermotherapy, along with four rounds of chemotherapy before surgery. The goal was to shrink tumors sufficiently to enable a breast-conserving lumpectomy procedure instead of the expected, and more invasive, mastectomy. Surgeons concluded that fourteen of the tumors shrunk enough for this to be possible.

In 1990, Dr. Alan J. Fenn, a senior staff member at MIT’s Lincoln Laboratory, adapted the thermotherapy treatment from a system that used focused microwaves to detect missiles and block out interfering enemy signals.

“It’s a very simple idea that can be applied to the treatment of many different cancers, including breast cancer,” Fenn said.

The microwaves, delivered by two applicators placed near the breast, kill the cancerous tissue while preserving normal breast tissue by targeting tumor cells that contain high amounts of both water and ions, Fenn explained. When the microwave energy passes through the tumor, the water molecules begin to vibrate and generate heat through friction. This process eventually elevates the cancer cells to a “high fever” of at least 108 degrees Fahrenheit in most cases, killing them.

“The treatment is well tolerated,” said Dr. Mary Beth Tomaselli, medical director at Comprehensive Breast Center in Coral Springs, Fla., and a surgeon who was also a co-investigator in the study. “The patients who have gone through it had minimal side effects and positive results.”

This is the fourth clinical trial of the therapy since 1999. In a Phase-I safety trial using microwave heat alone, researchers found that both small and large breast tumors could be decreased in size between 30 and 60 percent. In a Phase-II dose-escalation trial for small tumors, scientists increased the amount of heat until 100 percent of the tumor cells were killed, prior to the patients’ receiving a lumpectomy.

Next, researchers treated similar early-stage tumors and noticed that after the surgical removal, none of the patients had tumor cells remaining at the edge of the incision. This is important because additional breast surgery and/or radiation therapy are often recommended for patients that have cancer cells close to the edge of the lumpectomy surgical margin.

The treatment centers for the latest study, which focused on larger tumors, included Harbor-UCLA Medical Center in Torrance, Calif., the University of Oklahoma in Oklahoma City, Comprehensive Breast Center in Coral Springs, Fla., St. Joseph’s Hospital in Orange, Calif., and five additional sites. Celsion (Canada) Limited licenses the focused microwave thermotherapy technology from MIT, and has produced 10 clinical systems to date to perform the procedures.

The team has applied for approval for a large-scale clinical trial from Health Canada (the equivalent of the US FDA) and will be applying for the same approval from the FDA. Researchers will then test the treatment in a randomized study of 228 patients who have large breast-cancer tumors. Patients will receive either chemotherapy alone or chemotherapy plus microwave heat treatments at one of six participating medical centers in the United States and Canada.

“The patients who have the best results in cancer treatment, at least with breast cancer, are patients who have a sequence of different therapies, including chemotherapy, surgery, radiation, and hormones,” said Dr. Hernan I. Vargas, associate professor of surgery at UCLA and lead author of the recent study. “Each one of the treatments adds a little bit. The thermotherapy might be one more tool that helps us fight this disease.”

Source: Massachusetts Institute of Technology

New radar technology fights breast cancer
Treating breast cancer with a type of heat therapy derived from MIT radar research can significantly increase the effectiveness of chemotherapy, according to results from the fourth clinical trial of the technique reported online Nov. 25 in the journal Cancer Therapy.
Alternative breast imaging techniques sort abnormal from normal tissue
Dartmouth physicians and engineers have published a paper with results from a five-year project testing three new imaging techniques to examine breast abnormalities, including cancer. The study finds that the new methods of electromagnetic imaging offer a high contrast and the ability to distinguish between healthy breast tissue and abnormal tissue. Their study appears in the May 2007 issue of Radiology, the journal of the Radiological Society of North America.
Handheld 'T-ray' Device earns new $30,000 Lemelson-Rensselaer Student Prize
"T-rays" have been touted as the next breakthrough in sensing and imaging, but the need for bulky equipment has been an obstacle to reaching the field's potential. Enter Brian Schulkin, winner of the first-ever $30,000 Lemelson-Rensselaer Student Prize. Schulkin has invented an ultralight, handheld terahertz spectrometer — an advance that could help catapult T-ray technology from the lab bench to the marketplace.
Cancer therapy based on missile detection outlined in new book
A breast cancer treatment based on MIT research originally intended for detecting missiles is documented in a new book by Alan J. Fenn, an MIT researcher and inventor of the technique.
New findings may improve treatment of inherited breast cancer
Scientists have identified some of the elusive downstream molecules that play a critical role in the development and progression of familial breast cancer. The research, published by Cell Press in the October 10th issue of the journal Molecular Cell, also identifies a compound found in grapes and red wine as an excellent candidate for treatment of some forms of breast cancer.
Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute.
Herbal menopause therapy a good fit for breast cancer patients?
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer.
Egg whites solve the 3-D problem
The real world is three-dimensional. That's true even in the laboratory, where scientists have to grow cells to study how they develop and what happens when their growth is abnormal.

MIT radar technology fights breast cancer

Related stories:

News discussion: